Vilvet Pharmaceuticals Inc.
Vilvet Pharmaceuticals Inc. appears in FDA public data with 2 recalls, 0 510(k) clearances, 1 FDA inspection, and 1 compliance action on record. Its most recent recall (D-1488-2020, Class II) was initiated on July 24, 2020.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1488-2020 | Class II | VILEVEV MB Urinary Antispetic (81.0 mg methenamine, 40.8 mg sodium phosphate monobasic and 10.8 mg m | July 24, 2020 |
| D-1487-2020 | Class II | VILAMIT MB (118 mg methenamine, 36 mg phenyl salicylate, 40.8 mg sodium phosphate monobasic, 10.0 mg | July 24, 2020 |